Dermapharm Holding Balance Sheet Health
Financial Health criteria checks 3/6
Dermapharm Holding has a total shareholder equity of €587.2M and total debt of €1.0B, which brings its debt-to-equity ratio to 175.3%. Its total assets and total liabilities are €2.2B and €1.6B respectively. Dermapharm Holding's EBIT is €176.5M making its interest coverage ratio 4.3. It has cash and short-term investments of €117.4M.
Key information
175.3%
Debt to equity ratio
€1.03b
Debt
Interest coverage ratio | 4.3x |
Cash | €117.35m |
Equity | €587.20m |
Total liabilities | €1.59b |
Total assets | €2.17b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 0A5J's short term assets (€648.9M) exceed its short term liabilities (€414.3M).
Long Term Liabilities: 0A5J's short term assets (€648.9M) do not cover its long term liabilities (€1.2B).
Debt to Equity History and Analysis
Debt Level: 0A5J's net debt to equity ratio (155.3%) is considered high.
Reducing Debt: 0A5J's debt to equity ratio has reduced from 179.4% to 175.3% over the past 5 years.
Debt Coverage: 0A5J's debt is not well covered by operating cash flow (17.4%).
Interest Coverage: 0A5J's interest payments on its debt are well covered by EBIT (4.3x coverage).